beclomethasone dipropionate


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.

beclomethasone dipropionate

a glucocorticoid.
indications It is prescribed in a metered-dose inhaler in the maintenance treatment of bronchial asthma as prophylactic therapy and as an aerosol for inhalation to treat chronic rhinitis.
contraindications Status asthmaticus, acute asthma, or known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse reactions of systemic administration are the symptoms of adrenal insufficiency. Hoarseness, sore throat, and fungal infections of the oropharynx and larynx may occur. Good oral and dental hygiene after each use is requisite.

beclomethasone dipropionate

(bek″lŏ-meth′ă-sōn″, -zōn″)
A corticosteroid drug. Trade names are Vancenase and Beclovent.

beclomethasone dipropionate (bek´ləmeth´əsōn dī´prō´pēənāt´),

n brand names: oral–Beclovent, Vanceril; nasal–Vancenase AQ Nasal, Beconase AQ Nasal;
drug class: corticosteroid, synthetic;
action: prevents inflammation by depression of migration of polymorphonuclear leukocytes and fibroblasts and reversal of increased capillary permeability;
uses: chronic asthma and rhinitis.

beclomethasone dipropionate

a glucocorticoid, commonly used as an inhalant.
References in periodicals archive ?
Doull IJM, Freezer NJ, Holgate ST: Growth of prepuberal children with mild asthma treated with inhaled beclomethasone dipropionate.
The article is entitled "Evaluation of Oral Beclomethasone Dipropionate for the Prevention of Acute Graft-versus-Host Disease" and was posted online in Biology of Blood and Marrow Transplantation.
On July 28, 2011, Soligenix announced the expansion and amendment of its North American licensing partnership with Sigma-Tau for the development and commercialization of orBec (oral beclomethasone dipropionate or Oral BDP) into the European territory.
orBec, oral beclomethasone dipropionate (oral BDP), was recently the subject of a confirmatory Phase 3 clinical trial in the treatment of acute GI GVHD which was stopped for futility.
Sigma-Tau) for the development and commercialization of orBec (oral beclomethasone dipropionate or Oral BDP) into the European territory.
Our lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally-acting corticosteroid being developed for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD), a common serious complication of bone marrow transplantation for cancer, as well as other gastrointestinal disorders characterized by severe inflammation.
Tenders are invited for Each Ear Drop Contains Chlormphenicol 5 Percent W/V Clotrimazole 1 Percent W/V Beclomethasone Dipropionate 0.
Horgan will lead Soligenix's clinical research with primary focus on the execution and completion of its confirmatory Phase 3 clinical trial of orBec (oral beclomethasone dipropionate or BDP) in the treatment of acute gastrointestinal (GI) GVHD.
Contract awarded for beclomethasone dipropionate aerosol 50 mcg / spray, spray container 200-250 doses
Soligenix's lead product, orBec (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host-Disease (GI GVHD), a common and potentially life-threatening complication of hematopoietic cell transplantation.